logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > US Stock

iQiyi (IQ.US) financial report focus: Original TV series accounted for over 65% of total content. Gong Yu expressed plans to increase investment in top-tier content.

date
14:43 29/02/2024
avatar
GMT Eight
iQIYI's financial performance is strong.
Several major plays at the Season Mist Theater including "Unspeakable", "Above the Dark Clouds", "The Invisible Boy" and more.Hola, cmo ests?
Related Articles
HK Stock Market Move | CHERVON (02285) Rises Over 4% in Early Trading; Recruitment of New Senior Executives Continues; AI Infrastructure Drives Strong Demand for Power Tools
Allergy and autoimmune biotech company Lycia Therapeutics (LYCA.US) is set to list on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 million.
HK Stock Market Move | MAO GEPING (01318) rises over 5%, as the Double 11 promotion continues to catalyze, and the company's September GMV growth rate accelerates.
HK Stock Market Move | CHERVON (02285) Rises Over 4% in Early Trading; Recruitment of New Senior Executives Continues; AI Infrastructure Drives Strong Demand for Power Tools
Allergy and autoimmune biotech company Lycia Therapeutics (LYCA.US) is set to list on Nasdaq tonight! IPO priced at $18 per share, aiming to raise $317.5 million.
HK Stock Market Move | MAO GEPING (01318) rises over 5%, as the Double 11 promotion continues to catalyze, and the company's September GMV growth rate accelerates.
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.